triazolam has been researched along with ecopipam in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chausmer, AL; Griffiths, RR; Kelly, RY; Smith, BJ | 1 |
1 trial(s) available for triazolam and ecopipam
Article | Year |
---|---|
Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
Topics: Adult; Benzazepines; Blood Pressure; Cocaine-Related Disorders; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; GABA Modulators; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Pain Measurement; Receptors, Dopamine D1; Time Factors; Triazolam | 2003 |